| | Family Health | Baby Health
Fetal Surfactant Production: Timeline & Clinical Significance
Pulmonary surfactant (dipalmitoylphosphatidylcholine-rich lipoprotein) reduces alveolar surface tension, preventing atelectasis.
Developmental Timeline
| Gestational Age | Surfactant Milestone |
|---|---|
| ~20–24 weeks | Type II pneumocytes appear; lamellar bodies visible; minimal phospholipid synthesis |
| 24–28 weeks | Onset of measurable surfactant production; L/S ratio <2.0 |
| 30–34 weeks | Accelerated synthesis; L/S ratio approaches 2.0; PG appears |
| ≥35 weeks | Mature profile: L/S ratio ≥2.0, phosphatidylglycerol (PG) present |
| Term (37–40 wks) | Full surfactant pool; adequate for extrauterine transition |
Clinical Assessment
- Amniocentesis: L/S ratio, PG, fluorescence polarization (TDx FLM II) – guides delivery timing in high-risk pregnancies.
- Corticosteroids (betamethasone 12 mg IM q24h ×2) → ↑ surfactant synthesis 48 hrs post-dose; maximal effect 7 days; give 24 hrs–7 days before anticipated preterm birth (24–34 wks).
Respiratory Distress Syndrome (RDS)
- Surfactant deficiency → alveolar collapse → ventilation-perfusion mismatch → hypoxemia.
- Incidence: <30 wks ~60%, 34–36 wks ~5%, term <1%.
- Exogenous surfactant (beractant, poractant alfa, calfactant) via endotracheal tube – lifesaving.
Surfactant production begins ~24 weeks; maturity typically by 35 weeks; corticosteroids accelerate maturation.
Baby Health - Related Articles
- Newborn Not Crying at Birth: Causes, Assessment, and Reassurance
- Shaken Baby Syndrome (SBS): Symptoms, Causes, and Risks
- Understanding Preterm Infant Development: A Parent's Guide
- Neonatal Resuscitation: A Step-by-Step Guide for Lifesaving CPR
- Reborn Dolls: Exploring the Benefits and Considerations
- Effective Teething Relief: Proven Remedies for a Calm Baby
- Infant Diarrhea: Causes, Prevention & When to Seek Medical Help
